BusinessDay
Nigeria's leading finance and market intelligence news report.

India’s drug maker gets license to make Remdesivir to treat Covid-19

Indian generic drug maker Dr Reddy’s Laboratories has announced entering into a non-exclusive licensing agreement with Gilead Sciences, which grants the Indian firm the rights to register, manufacture and sell the American biopharmaceutical firm’s investigational drug Remdesivir, a potential treatment for Covid-19. The rights to register, manufacture and sell the drug were granted for 127…



Join the BusinessDay Inner Circle to read exclusives and gain insights for N1000/month

Get real time updates directly on you device, subscribe now.

Comments are closed.